CANSINO BIOLOGICS INC

688185 | SHANGHAI STOCK EXCHANGE
Business Summary
CanSino Biologics Inc is a clinical-stage vaccine company in China. The Company's products include Ad5-EBOV vaccine used for Ebola virus, MCV2 and MCV4 vaccines for meningococcus, PBPV vaccine used for pneumococcal and the recombinant novel coronavirus vaccine. Its products are mainly used in meningitis, diphtheria pertussis tetanus (DPT) and pneumonia.
Country of Incorporation
China
Incorporation Date
2009-01-13
Business Sector
Pharmaceuticals & Medical Research
Company Address
West District Biomedical Park, No. 185 South Avenue, West District, Economic and Technological Development Zone
Get access to the below data and more business development tools by signing up for the MENA Company Data product.
- Ownership details
- Corporate structure
- Business classification
- Officers & Directors contact details
- Full company contact details
Find out more
Multiply your reach by contributing your content to LSEG
LSEG contributed content reaches tens of thousands of buy and sell side professionals around the world through an integrated suite of market intelligence and transaction platforms.

NEWS ON THIS COMPANY

Find companies

ZAWYA NEWSLETTERS

Get insights and exclusive content from the world of business and finance that you can trust, delivered to your inbox.

Subscribe to our newsletters: